IGENOMIX S L has a total of 31 patent applications. Its first patent ever was published in 2013. It filed its patents most often in EPO (European Patent Office), WIPO (World Intellectual Property Organization) and China. Its main competitors in its focus markets pharmaceuticals, biotechnology and measurement are UNI AUT NOMA DE BARCELONA, GOVT OF THE USA AS REPRESENTED and NETHERLANDS CANCER INST.
# | Country | Total Patents | |
---|---|---|---|
#1 | EPO (European Patent Office) | 5 | |
#2 | WIPO (World Intellectual Property Organization) | 5 | |
#3 | China | 4 | |
#4 | Brazil | 3 | |
#5 | Canada | 3 | |
#6 | United States | 3 | |
#7 | Mexico | 2 | |
#8 | Australia | 1 | |
#9 | Hong Kong | 1 | |
#10 | Hungary | 1 | |
#11 | Japan | 1 | |
#12 | Serbia | 1 | |
#13 | Russian Federation | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Measurement | |
#4 | Medical technology | |
#5 | Machines |
# | Name | Total Patents |
---|---|---|
#1 | Simon Carlos | 16 |
#2 | Pellicer Antonio | 14 |
#3 | Cervello Irene | 10 |
#4 | Santamaria Javier | 9 |
#5 | Garrido Tamara | 8 |
#6 | Antonio Pellicer | 5 |
#7 | Simón Carlos | 5 |
#8 | Tamara Garrido | 4 |
#9 | Fisher Susan | 4 |
#10 | Carlos Simón | 3 |
Publication | Filing date | Title |
---|---|---|
CN112143785A | Method for evaluating endometrial receptivity of a patient and kit for carrying out the method | |
WO2020212588A1 | Non-invasive assay for pre-eclampsia and conditions associated with pre-eclampsia | |
WO2020212580A1 | Improved methods for the early diagnosis of uterine leiomyomas and leiomyosarcomas | |
WO2019246160A2 | Methods for assessing endometrial transformation | |
US2019276890A1 | Gene expression profile as an endometrial receptivity marker | |
CN111630387A | Methods and devices for detecting preeclampsia-related biomarkers | |
MX2016016756A | Stem cell therapy in endometrial pathologies. | |
MX2016012278A | Early detection of preeclampsia. | |
HK1177636A1 | Diagnostic method for endometrial receptivity |